Chinese Biotechs Raise $743m In Three March IPOs

 
• By Dexter Jie Yan
  
The first biotech IPO on the Beijing Stock Exchange
combined $742.9m in gross proceeds closed out strong March for RemeGen, Recbio and Shouyao • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia